Astellas Research Institute of America (ARIA) is the Astellas global hub for neuroscience research. Established in June 2017 and headquartered in La Jolla, California, ARIA’s drug discovery and development prioritizes advancing the field of neuroscience, specifically targeting areas of high unmet need in conditions of the central nervous system (CNS).
The researchers at ARIA are exploring ways to address the world’s most challenging CNS disorders, such as schizophrenia and bipolar disorder. Their goal is to develop therapies to alleviate or lessen the burden of psychiatric disorders. ARIA researchers hope to offer new treatment options to schizophrenic patients suffering from psychosis and cognitive impairment and to bipolar disorder patients undergoing manic or depressive episodes.
As a global company committed to improving the lives of people around the world with innovative and effective medicines, the expansion of ARIA as a hub for R&D efforts in the United States is yet another step for Astellas in advancing the worldwide effort to ease burdens of the central nervous system.
For more information on career opportunities at AIRA, click here.